ABSTRACT
Objective To assess the current level of seasonal influenza vaccine acceptance in England and establish the evolving socio-demographic determinants of seasonal influenza uptake and intent-to-vaccinate behaviours between 2020 and 2022. To provide a framework for predicting future rates of seasonal influenza uptake at sub-national scales in England.
Design Two cross-sectional online surveys analysed using a Bayesian time-series multilevel model followed by poststratification to re-weight against English census data.
Setting England, September 2020 to July 2022.
Participants 28,748 English adults, 18 years of age and older.
Main outcome measures Three response variables: whether an individual was offered a seasonal influenza vaccine on the NHS in the last 12 months, whether this offer was accepted, and whether they would accept a seasonal influenza vaccine in the next 12 months.
Results In the 2021-22 flu season, 56.3% of adults in England were offered the seasonal influenza vaccine, marking a significant increase of 10.7 percentage points compared to the 2019-20 season, due to the expanded rollout of the programme during the pandemic. Acceptance of the seasonal influenza vaccine saw a marked rise during this period across most age groups and particularly among individuals aged 50 and over. However, intentions to accept the vaccine in the next 12 months showed a slight decline across the English adult population between 2020 and 2022 surveys. Socio-demographic traits play a significant role in shaping vaccine behaviours, with age, gender, education, ethnicity, and religion influencing the likelihood of being offered the vaccine, accepting it when offered, and intending to receive future vaccinations. Noteworthy differences were observed across demographic groups, particularly between Black/Black British and White respondents, although gaps in acceptance between socio-demographic groups in the 65-and-over cohort were narrower than for population as a whole. Of particular concern is waning intent-to-accept behaviours among Asian and Asian British groups, as well as Hindus and Punjabi speakers. Regional disparities also emerged, with estimates for flu vaccine receipt and future intent to accept a flu vaccine relatively low in London, especially inner London. Predictions of flu vaccine uptake generated from 2022 data correlated well with the observed UK Health Security Agency-reported uptake in the subsequent 2022-23 flu season, highlighting the ability of multilevel regression and poststratification to accurately capture future intentions.
Conclusions The findings underscore the significant progress made in increasing seasonal influenza vaccine uptake among adults in England during the 2021-22 flu season. Despite these improvements, disparities persist across socio-demographic groups, spotlighting the need for targeted interventions to address uptake inequity. The slight decline in intention to accept the vaccine in the general adult population warrants attention. Furthermore, regional disparities emphasise the importance of tailoring vaccination strategies to address specific geographical contexts. The strong correlation between predicted and observed vaccine uptake and observed indicates the utility of predictive modelling in informing future vaccination behaviours and public health interventions. Overall, these findings provide valuable insights for policymakers and public health practitioners to enhance influenza vaccination efforts and mitigate the burden of influenza-related illness in England.
Competing Interest Statement
AF and LL have been involved in Vaccine Confidence Project research grants from GlaxoSmithKline (GSK) and Merck (MSD). These research grants are not associated with the project at hand, but related to research on vaccine confidence around different vaccines. AF has performed consultancy work for Pfizer Inc within the last 24 months. SMJ and PP are affiliated to the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Vaccines and Immunisation (NIHR200929) at London School of Hygiene and Tropical Medicine in partnership with UK Health Security Agency (UKHSA). SMJ and PP are based at LSHTM. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or UKHSA.
Funding Statement
AF and LL would like to acknowledge funding from AIR@InnoHK administered by the Innovation and Technology Commission of the Government of the Hong Kong Special Administrative Region.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Survey data collection from 2020 was approved by the Imperial College Research Ethics Committee on 24 July 2020 with reference 20IC6133. Survey data collection from 2022 was approved on 31 March 2022 by the London School of Hygiene & Tropical Medicine's Ethics Committee with reference 26854.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Study data is available upon request from the corresponding author.